Literature DB >> 11311507

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression.

C Minov1, T C Baghai, C Schüle, P Zwanzger, M J Schwarz, P Zill, R Rupprecht, B Bondy.   

Abstract

Disturbances in serotonergic neurotransmission system have been implicated in the etiology of mood disorders. As the importance of genetic factors is well established, genes encoding for proteins of the serotonergic pathway are important candidates to unravel the underlying genetic contribution. We examined two polymorphisms in the serotonin-2A-receptor gene (5-HT2A; T102C and His452Tyr) and the insertion/deletion polymorphism in the promoter region of the serotonin transporter (5-HTTLPR) in a sample of 173 patients with major depression and 121 healthy controls. No statistical significant differences between patients and controls were found for any of the three investigated polymorphisms, neither in the distribution of the genotypes nor in allele frequencies. However, concerning the 5-HTTLPR polymorphism, the frequency of S/S (short allele) homozygotes was higher (23.1%) than in the control group (14.0%), but this failed to reach significance. Moreover we observed a different treatment response in patients with one or two C-alleles of the T102C polymorphism, with a significantly higher decrease in HAMD-17 (ANOVA: d.f. = 1, F = 5,288, P = 0.023) after 4 weeks of antidepressant treatment. Overall our results suggest that the investigated 5-HT2A and 5-HTTLPR polymorphisms are not major susceptibility factors in the etiology of major depression. However, subtypes might be identified at least on a basis of differential treatment response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311507     DOI: 10.1016/s0304-3940(01)01704-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Candidate gene associations with withdrawn behavior.

Authors:  David H Rubin; Robert R Althoff; Erik A Ehli; Gareth E Davies; David C Rettew; Eileen T Crehan; John T Walkup; James J Hudziak
Journal:  J Child Psychol Psychiatry       Date:  2013-06-28       Impact factor: 8.982

Review 3.  [The value of pharmacogenetic tests in antidepressive medication therapy].

Authors:  J Kirchheiner; J Sasse; I Roots; J Brockmöller; M Bauer
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

Review 4.  Contribution of allelic variations to the phenotype of response to antidepressants and antipsychotics.

Authors:  Wolfgang Maier; Astrid Zobel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

5.  Serotonin transporter gene: a new polymorphism may affect response to antidepressant treatments in major depressive disorder.

Authors:  Yoshihiko Matsumoto; Chiara Fabbri; Silvia Pellegrini; Stefano Porcelli; Pierluigi Politi; Silvio Bellino; Caterina Iofrida; Veronica Mariotti; Erika Melissari; Marco Menchetti; Valentina Martinelli; Marco Cappucciati; Paola Bozzatello; Elena Brignolo; Paolo Brambilla; Matteo Balestrieri; Alessandro Serretti
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

Review 6.  Platelets and depression in cardiovascular disease: A brief review of the current literature.

Authors:  Marlene S Williams
Journal:  World J Psychiatry       Date:  2012-12-22

Review 7.  Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

8.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

Review 9.  Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter.

Authors:  Alexander Neumeister; Theresa Young; Juergen Stastny
Journal:  Psychopharmacology (Berl)       Date:  2004-07-13       Impact factor: 4.530

10.  Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Authors:  Alessandro Serretti; Paola Artioli; Raffaella Zanardi; Cristina Lorenzi; David Rossini; Cristina Cusin; Alessia Arnoldi; Marco Catalano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.